April 20, 2014
(Jutia Group, 10/29/13)
[at noodls] - The Dow Chemical Company (NYSE: DOW) and Cambrex (NYSE: CBM) celebrated...(read more)
Cambrex Corporation (NYSE: CBM) announced today that it acquired a 51% stake in Zenara Pharma, a Hyderabad, India based pharmaceutical company focused on the formulation of final dosage form products. Cambrex acquired a 51% equity...(read more)
Cambrex Corporation (NYSE: CBM) reports third quarter results for the period ended September 30, 2010. Highlights * Reported sales decreased by 14.6%, and excluding the impact of foreign currency, sales decreased 11.5% compared...(read more)
Cambrex (CBM) Company Overview
There is no analysis for CBM yet. But you can go to Wikinvest to help create one!